SW, Room 636G DHHS/OS/OPHEP/ORDC 200 Independence Ave Washington, DC 20201 Human Genome Sciences, Inc. 14200 Shady Grove Road Rockville, MD 20850 DUNS 79-705-7437 FOB ORIGIN OTHER (SEE below!Supplemental Agreement • August 9th, 2006 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances
[XI SEC. DESCRIPTION PAGE IS! (X) SEC. DESCRIPTION PAGE(S) —— —— —— —— —— —— —— — PART I — THE SCHEDULE PART II — CONTRACT CLAUSES —— — X A SOLICITATION/CONTRACT FORM 1 x 1 CONTRACT CLAUSES 34 —— —— —— —— —— —— —— — x B SUPPLIES OR SERVICES AND PRICES/COSTS 2 PART III — LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH. —— —— —— —— — X C DESCRIPTION/SPECS. /WORK STATEMENT 8 X J LiST OF ATTACHMENTS 38 —— —— —— —— —— —— —— — X D PACKAGING AND MARKING 16 PART IV REPRESENTATIONS AND INSTRUCTIONS —— —— —— —— — REPRESENTATIONS, CERTIFICATIONS AND OTHER X E INSPECTION AND ACCEPTANCE 17 K STATEMENTS OF OFFERORS —— —— —— — X F DELIVERIES OR PERFORMANCE 18 —— —— —— — X G CONTRACT ADMINISTRATION DATA 21 L 1NSTRS., CONDS., AND NOTICES TO OFFERORS —— —— —— —— —— — X H SPECIAL CONTRACT REQUIREMENTS 25 M EVALUATION FACTORS FOR AWARD —— —— —— —— —— — CONTRACTING OFFICER WILL COM ‘LETEITEM 17 OR 18 AS APPLICABLE —— — 17 CONTRACTOR S NEGOTIATED AGREEMENT (Contractor is required to sign this document and retu
AGREEMENT OF PURCHASE AND SALE (9911 Belward Campus Drive & Traville Property, Rockville Maryland)Agreement of Purchase and Sale • August 9th, 2006 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances
This Agreement of Purchase and Sale (“Agreement”) is made as of the 2nd day of May 2006 (“Effective Date”) between Human Genome Sciences, Inc., a Delaware corporation (“Seller”), and BioMed Realty, L.P., a Maryland limited partnership (“Purchaser”).
CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN HUMAN GENOME SCIENCES, INC. AND NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.Development and Commercialization Agreement • August 9th, 2006 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances • New York
THIS EXCLUSIVE LICENSE AGREEMENT is made effective as of the 5th day of June 2006 (“Effective Date”) by and between Human Genome Sciences, Inc., a Delaware corporation having its principal place of business at 14200 Shady Grove Road, Rockville, Maryland 20850 (“HGS”), and Novartis International Pharmaceutical Ltd., a Bermuda corporation having its principal place of business at Hurst Holme, 12 Trott Road, Hamilton, HM 11, Bermuda (“NVS”). HGS and NVS are each referred to individually as a “Party” and together as the “Parties.”
